Equities

Daiken Medical Co Ltd

7775:TYO

Daiken Medical Co Ltd

Actions
Health CareMedical Equipment and Services
  • Price (JPY)504.00
  • Today's Change0.00 / 0.00%
  • Shares traded19.70k
  • 1 Year change-4.36%
  • Beta0.4860
Data delayed at least 20 minutes, as of Nov 15 2024 06:30 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2,7392,5162,519
Total Receivables, Net2,4802,5302,431
Total Inventory1,4381,5151,545
Prepaid expenses251920
Other current assets, total505858
Total current assets6,7316,6396,572
Property, plant & equipment, net3,9874,0704,119
Goodwill, net------
Intangibles, net139.4115
Long term investments0.010.010.01
Note receivable - long term131313
Other long term assets505038
Total assets11,00611,01310,921
LIABILITIES
Accounts payable1,0641,110991
Accrued expenses172115147
Notes payable/short-term debt1,0801,0001,000
Current portion long-term debt/capital leases398670609
Other current liabilities, total626475405
Total current liabilities3,3403,3693,151
Total long term debt6371,0411,317
Total debt2,1152,7112,926
Deferred income tax------
Minority interest------
Other liabilities, total6.716.116.26
Total liabilities3,9844,4164,475
SHAREHOLDERS EQUITY
Common stock496496496
Additional paid-in capital401401401
Retained earnings (accumulated deficit)7,9527,5277,376
Treasury stock - common(1827)(1827)(1827)
Unrealized gain (loss)------
Other equity, total0----
Total equity7,0226,5976,446
Total liabilities & shareholders' equity11,00611,01310,921
Total common shares outstanding292929
Treasury shares - common primary issue3.113.113.11
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.